Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Public health applications of CRISPR: How children's health can benefit.

Vigliotti VS, Martinez I.

Semin Perinatol. 2018 Dec;42(8):531-536. doi: 10.1053/j.semperi.2018.09.017. Epub 2018 Oct 2. Review.

PMID:
30482591
2.

Editing nature: Local roots of global governance.

Kofler N, Collins JP, Kuzma J, Marris E, Esvelt K, Nelson MP, Newhouse A, Rothschild LJ, Vigliotti VS, Semenov M, Jacobsen R, Dahlman JE, Prince S, Caccone A, Brown T, Schmitz OJ.

Science. 2018 Nov 2;362(6414):527-529. doi: 10.1126/science.aat4612. Epub 2018 Nov 1. No abstract available.

PMID:
30385564
3.

Dynamic Models of Infectious Disease Transmission in Prisons and the General Population.

Ndeffo-Mbah ML, Vigliotti VS, Skrip LA, Dolan K, Galvani AP.

Epidemiol Rev. 2018 Jun 1;40(1):40-57. doi: 10.1093/epirev/mxx014.

4.

From Human Papillomavirus (HPV) Detection to Cervical Cancer Prevention in Clinical Practice.

Lee SH, Vigliotti JS, Vigliotti VS, Jones W.

Cancers (Basel). 2014 Oct 2;6(4):2072-99. doi: 10.3390/cancers6042072.

5.

DNA sequencing diagnosis of off-season spirochetemia with low bacterial density in Borrelia burgdorferi and Borrelia miyamotoi infections.

Lee SH, Vigliotti JS, Vigliotti VS, Jones W, Moorcroft TA, Lantsman K.

Int J Mol Sci. 2014 Jun 25;15(7):11364-86. doi: 10.3390/ijms150711364.

6.

Detection of borreliae in archived sera from patients with clinically suspect Lyme disease.

Lee SH, Vigliotti JS, Vigliotti VS, Jones W, Shearer DM.

Int J Mol Sci. 2014 Mar 11;15(3):4284-98. doi: 10.3390/ijms15034284.

7.

Early Lyme disease with spirochetemia - diagnosed by DNA sequencing.

Lee SH, Vigliotti VS, Vigliotti JS, Jones W, Williams J, Walshon J.

BMC Res Notes. 2010 Nov 1;3:273. doi: 10.1186/1756-0500-3-273.

8.

Increased sensitivity and specificity of Borrelia burgdorferi 16S ribosomal DNA detection.

Lee SH, Vigliotti VS, Vigliotti JS, Jones W, Pappu S.

Am J Clin Pathol. 2010 Apr;133(4):569-76. doi: 10.1309/AJCPI72YAXRHYHEE.

PMID:
20231610
9.

Signature sequence validation of human papillomavirus type 16 (HPV-16) in clinical specimens.

Lee SH, Vigliotti VS, Pappu S.

J Clin Pathol. 2010 Mar;63(3):235-9. doi: 10.1136/jcp.2009.069401. Epub 2009 Oct 26.

10.

Validation of human papillomavirus genotyping by signature DNA sequence analysis.

Lee SH, Vigliotti VS, Vigliotti JS, Pappu S.

BMC Clin Pathol. 2009 May 22;9:3. doi: 10.1186/1472-6890-9-3.

11.

Molecular tests for human papillomavirus (HPV), Chlamydia trachomatis and Neisseria gonorrhoeae in liquid-based cytology specimen.

Lee SH, Vigliotti VS, Pappu S.

BMC Womens Health. 2009 Apr 9;9:8. doi: 10.1186/1472-6874-9-8.

12.

HPV infection among women in a representative rural and suburban population of the USA.

Lee SH, Vigliotti VS, Pappu S.

Int J Gynaecol Obstet. 2009 Jun;105(3):210-4. doi: 10.1016/j.ijgo.2009.01.019. Epub 2009 Feb 28.

PMID:
19251258
13.

DNA sequencing validation of Chlamydia trachomatis and Neisseria gonorrhoeae nucleic acid tests.

Lee SH, Vigliotti VS, Pappu S.

Am J Clin Pathol. 2008 Jun;129(6):852-9. doi: 10.1309/Y2202RVCGRWW1RWB.

PMID:
18480000
14.

Routine human papillomavirus genotyping by DNA sequencing in community hospital laboratories.

Lee SH, Vigliotti VS, Vigliotti JS, Pappu S.

Infect Agent Cancer. 2007 Jun 5;2:11.

Supplemental Content

Loading ...
Support Center